Search
for
Sort by
Research 91–120 of 1000+
- Risks Associated with 5α-Reductase Inhibitor Use: Analysis of Adverse Drug Reactions Reported to EudraVigilance
- Persistent Erectile Dysfunction after Discontinuation of 5-Alpha Reductase Inhibitor Therapy in Rats Depending on the Duration of Treatment
- Post-SSRI sexual dysfunction & other enduring sexual dysfunctions
- Inhibitors of 5α-reductase-related side effects in patients seeking medical care for sexual dysfunction.
- The Dark Side of 5α-Reductase Inhibitors' Therapy: Sexual Dysfunction, High Gleason Grade Prostate Cancer and Depression
- Testosterone therapy for sexual dysfunction in postmenopausal women
- Female sexuality and common sexual dysfunctions: evaluation and management in a primary care setting
- Sexual dysfunction, including hypoactive sexual desire disorder: Diagnosis and treatment recommendations
- Summary of the Recommendations on Sexual Dysfunctions in Women
- Treatment of female sexual dysfunction in postmenopausal women—What is the evidence?
- Characteristics of Men Who Report Persistent Sexual Symptoms After Finasteride Use for Hair Loss
- Impact of Hormones on Female Sexual Function and Dysfunction
- REPORTS: Summary of the Recommendations on Sexual Dysfunctions in Women
- Diagnostic criteria for enduring sexual dysfunction after treatment with antidepressants, finasteride and isotretinoin
- 1153 ERECTILE HEMODYNAMICS ASSESSMENT IN MEN WITH PERSISTENT ERECTILE DYSFUNCTION AFTER 5-ALPHA REDUCTASE INHIBITOR USE
- Re: Risk of Erectile Dysfunction Associated with Use of 5α-Reductase Inhibitors for Benign Prostatic Hyperplasia or Alopecia: Population Based Studies Using the Clinical Practice Research Datalink
- Negative Impact of Testosterone Deficiency and 5α-Reductase Inhibitors Therapy on Metabolic and Sexual Function in Men
- Estimating the risk of irreversible post-SSRI sexual dysfunction (PSSD) due to serotonergic antidepressants
- Penile vascular abnormalities in young men with persistent side effects after finasteride use for the treatment of androgenic alopecia
- Health consequences of anabolic steroids: a sexual-medicine perspective
- Finasteride 1 mg in alopecia: sexual dysfunction, suicidal ideation. Providing balanced information to male patients is key.
- Sexual Dysfunction in Polycystic Ovary Syndrome (PCOS): A Biopsychosocial Approach to Assessment and Management
- Risk assessment of the top 60 drugs for drug-related sexual dysfunction: a disproportion analysis from the Food and Drug Administration adverse event reporting system
- Management of Sexual Dysfunction in Postmenopausal Breast Cancer Patients Taking Adjuvant Aromatase Inhibitor Therapy
- Immunohistochemical Evaluation of Androgen Receptor and Nerve Structure Density in Human Prepuce from Patients with Persistent Sexual Side Effects after Finasteride Use for Androgenetic Alopecia
- Impact of Alpha Blockers, 5-alpha Reductase Inhibitors and Combination Therapy on Sexual Function
- The Neurobiology of Sexual Function
- Abstracts from the current global literature: Finasteride and sexual dysfunction
- Depressive Symptoms and Suicidal Thoughts Among Former Users of Finasteride With Persistent Sexual Side Effects
- Duration of finasteride and dutasteride treatment linked to long-term erectile dysfunction